John J Monahan

Title: The Innovative Contributions of John J Monahan

Introduction

John J Monahan is a notable inventor based in Orinda, CA (US), recognized for his significant contributions to the field of oncology. With a total of 4 patents, Monahan has developed innovative methods and compositions that enhance the diagnosis and treatment of cancer.

Latest Patents

Monahan's latest patents include groundbreaking work on the c-erbB-2 oncogene. One of his notable inventions involves methods for identifying malignant tumors that overexpress the c-erbB-2 oncogene. This patent provides assays useful for the diagnosis and prognosis of neoplastic diseases by detecting the external domain of c-erbB-2, specifically the glycoprotein gp75. The invention also includes recombinant proteins and polypeptides encoded by the c-erbB-2 oncogene, which can be utilized as vaccines or therapeutically in cancer treatment. Another significant patent focuses on novel combinations of ligand-mimicking agents and anti-neoplastic drugs, aimed at treating patients suspected of having cancer. This combination is particularly effective for inhibiting the growth of breast and ovarian tumor cells.

Career Highlights

Throughout his career, Monahan has worked with prominent companies such as Berlex Laboratories, Inc. and Schering Aktiengesellschaft. His work in these organizations has contributed to the advancement of cancer therapies and diagnostics.

Collaborations

Monahan has collaborated with notable professionals in the field, including Laura K Shawver and John W Brandis. These partnerships have further enhanced the impact of his inventions in the medical community.

Conclusion

John J Monahan's innovative work in cancer research and treatment exemplifies the vital role of inventors in advancing medical science. His contributions continue to influence the diagnosis and therapy of malignant tumors, showcasing the importance of innovation in healthcare.